Cullinan Therapeutics (CGEM) FCF Margin (2021)
Cullinan Therapeutics (CGEM) has 1 years of FCF Margin data on record, last reported at 8.0% in Q1 2021.
- For Q1 2021, FCF Margin changed N/A year-over-year to 8.0%; the TTM value through Dec 2021 reached 229.28%, changed N/A, while the annual FY2021 figure was 229.28%, N/A changed from the prior year.
- FCF Margin reached 8.0% in Q1 2021 per CGEM's latest filing.
- Across five years, FCF Margin topped out at 8.0% in Q1 2021 and bottomed at 8.0% in Q1 2021.